FLEXBUMIN (Baxalta US Inc.)


Welcome to the PulseAid listing for the FLEXBUMIN drug offered from Baxalta US Inc.. This Human Serum Albumin [EPC],Increased Intravascular Volume [PE],Increased Oncotic Pressure [PE],Osmotic Activity [MoA],Serum Albumin [Chemical/Ingredient] pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
LABELER NAME / MANUFACTURER: Baxalta US Inc.
NON-PROPRIETARY NAME: Albumin Human
SUBSTANCE NAME: ALBUMIN HUMAN
TYPE: PLASMA DERIVATIVE
PHARMA CLASS: Human Serum Albumin [EPC],Increased Intravascular Volume [PE],Increased Oncotic Pressure [PE],Osmotic Activity [MoA],Serum Albumin [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2002-08-09
END MARKETING DATE: 0000-00-00


FLEXBUMIN PLASMA DERIVATIVE Details:

Item DescriptionFLEXBUMIN from Baxalta US Inc.
LABELER NAME: Baxalta US Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 0.25(g/mL)
START MARKETING DATE: 2002-08-09
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0944-0493_70257164-41dd-45da-ae6b-a011a4b21be6
PRODUCT NDC: 0944-0493
APPLICATION NUMBER: BLA101452

Other ALBUMIN HUMAN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Baxalta US Inc.Buminate
CSL Behring AGAlbuRx
GRIFOLS USA, LLCALBUTEIN
KEDRION BIOPHARMA, INC.Albuked